Table 2.
Characteristics | No. of patients
|
|||
---|---|---|---|---|
Group 1 | Group 2 | Group 3 | Total | |
Number of patients | 9 | 9 | 9 | 27 |
Stage 4 NED | 5 | 5 | 5 | 15 |
Stage 4 stable disease | 4 | 4 | 4 | 12 |
Patients with prior chemotherapy | ||||
None | 2 | 1 | 1 | 4 |
Adjuvant only | 0 | 4 | 1 | 5 |
Metastatic only | 5 | 1 | 1 | 7 |
Adjuvant + metastatic | 2 | 3 | 6 | 11 |
Patients with prior radiotherapy | ||||
None | 2 | 2 | 0 | 4 |
Adjuvant only | 1 | 2 | 1 | 4 |
Metastatic only | 5 | 4 | 5 | 14 |
Adjuvant + metastatic | 1 | 1 | 3 | 5 |
Patients on hormone therapy during the study | 6 | 9 | 7 | 22 |
NED, no evidence of disease.